<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3316</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.13223</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>The Study of Anti-inflammatory and Analgesic Effects of Oral Serratiopeptidasein Postoperative Patients in a Tertiary Care Hospital&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khanwelkar</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Peethambaran</surname><given-names>Kartik</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jadhav</surname><given-names>S. A.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>16</day><month>01</month><year>2021</year></pub-date><volume>)</volume><issue/><fpage>85</fpage><lpage>89</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Oral proteolytic enzymes like serratiopeptidase are very commonly used by clinicians either alone or in combination with non-steroidal anti-inflammatory drugs for analgesia and anti-inflammatory and wound healing purpose in postoperative patients. Objective: To study the effect of serratiopeptidase and diclofenac in postoperative patients. Methods: Three groups (n= 20) of postoperative patients having clean surgical wound were treated with diclofenac 50 mg twice a day (BID) and serratiopeptidase 10mg three times a day (TID) + Diclofenac 50 mg BID for one week. The third group was not given any analgesic- anti-inflammatory drug. The pain and inflammation at the site of the wound were assessed by VAS and Asepsis score on 1st and 7th day. Results: No difference in analgesic and anti-inflammatory effects were found in both treatment groups (p__ampersandsigngt; 0.05). Patients in the no-treatment group had relief of inflammation comparable to both treatment groups. Patients from no treatment group did not require analgesic for pain relief. Conclusion: Addition of serratiopeptidase did not potentiate the analgesic and anti-inflammatory effects of diclofenac. In clean surgical wounds, use of analgesic anti-inflammatory drugs should be as per need and not on regular basis.&#13;
</p></abstract><kwd-group><kwd>Serratiopeptidase</kwd><kwd> Diclofenac</kwd><kwd> Analgesic</kwd><kwd> Anti-inflammatory</kwd><kwd> Postoperative</kwd><kwd> Surgical wound.</kwd></kwd-group></article-meta></front></article>
